A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED)

Merck Sharp & Dohme (MSD)

Status and phase: Completed; Phase 3

Conditions: Postoperative Pain

Treatments: Drug: MK0966, rofecoxib; Drug: Comparator: valdecoxib

Study type: Interventional

Funder types: Industry

Identifiers

NCT00092300

0966-181

2004_066

Details and patient eligibility

About

The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following dental surgery.

Full description

The duration of treatment is 1 day.

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Impaction of a molar tooth requiring removal

Exclusion criteria

• Known allergies to the study drug

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind